Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
Authors
Keywords
-
Journal
Oncogenesis
Volume 4, Issue 2, Pages e137-e137
Publisher
Springer Nature
Online
2015-02-09
DOI
10.1038/oncsis.2014.51
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Epigenetic Changes Modulate Schistosome Egg Formation and Are a Novel Target for Reducing Transmission of Schistosomiasis
- (2014) Vitor Coutinho Carneiro et al. PLoS Pathogens
- The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high-risk neuroblastoma
- (2012) So Young Yoo et al. CANCER
- Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma
- (2012) Timothy B. Lautz et al. JOURNAL OF PEDIATRIC SURGERY
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma
- (2012) Timothy B. Lautz et al. PLoS One
- Rhodanine carboxylic acids as novel inhibitors of histone acetyltransferases
- (2012) Silviya D. Furdas et al. MedChemComm
- Small Molecule Inhibitors of Histone Acetyltransferases as Epigenetic Tools and Drug Candidates
- (2011) Silviya D. Furdas et al. ARCHIV DER PHARMAZIE
- Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors
- (2011) Silviya D. Furdas et al. BIOORGANIC & MEDICINAL CHEMISTRY
- CPTH6, a Thiazole Derivative, Induces Histone Hypoacetylation and Apoptosis in Human Leukemia Cells
- (2011) D. Trisciuoglio et al. CLINICAL CANCER RESEARCH
- Cancer Chemoprevention by Targeting the Epigenome
- (2011) Joseph Huang et al. CURRENT DRUG TARGETS
- Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
- (2011) F. R. Santer et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the epigenome for treatment of cancer
- (2011) E-J Geutjes et al. ONCOGENE
- Isothiazolones; thiol-reactive inhibitors of cysteine protease cathepsin B and histone acetyltransferase PCAF
- (2011) Rosalina Wisastra et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation
- (2011) L. Wang et al. SCIENCE
- Small molecule inhibitors of histone acetyltransferase Tip60
- (2010) Jiang Wu et al. BIOORGANIC CHEMISTRY
- Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells
- (2010) Cao Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MYST-family histone acetyltransferases: beyond chromatin
- (2010) Vasileia Sapountzi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- New Potent Bisubstrate Inhibitors of Histone Acetyltransferase p300: Design, Synthesis and Biological Evaluation
- (2010) Franciane Ho A Kwie et al. Chemical Biology & Drug Design
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
- (2010) Erin M. Bowers et al. CHEMISTRY & BIOLOGY
- Nitric Oxide-Mediated Histone Hyperacetylation in Oral Cancer: Target for a Water-Soluble HAT Inhibitor, CTK7A
- (2010) Mohammed Arif et al. CHEMISTRY & BIOLOGY
- Tuning acetylated chromatin with HAT inhibitors: A novel tool for therapy
- (2010) Stefano Vernarecci et al. Epigenetics
- Steroid Receptor Coactivator (SRC) Family: Masters of Systems Biology
- (2010) Brian York et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The histone deacetylase inhibitor LBH589 enhances the anti-myeloma effects of chemotherapy in vitro and in vivo
- (2010) Eric Sanchez et al. LEUKEMIA RESEARCH
- Chemical biology of Histone acetyltransferase natural compounds modulators
- (2010) Fabrizio Dal Piaz et al. MOLECULAR DIVERSITY
- Sanguinarine Interacts with Chromatin, Modulates Epigenetic Modifications, and Transcription in the Context of Chromatin
- (2009) Ruthrotha Selvi B et al. CHEMISTRY & BIOLOGY
- Histone acetyl transferases as emerging drug targets
- (2009) Frank J. Dekker et al. DRUG DISCOVERY TODAY
- The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease
- (2009) O. Gojis et al. EJSO
- Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase
- (2009) Massimo Ghizzoni et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Histone acetyltransferase inhibitors and preclinical studies
- (2009) Fabio Manzo et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
- (2009) F. Colland et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetics in cancer: Targeting chromatin modifications
- (2009) L. Ellis et al. MOLECULAR CANCER THERAPEUTICS
- The role of SRC-3 in human breast cancer
- (2009) Ondrej Gojis et al. Nature Reviews Clinical Oncology
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
- (2008) I. Fichtner et al. CLINICAL CANCER RESEARCH
- The structural basis of protein acetylation by the p300/CBP transcriptional coactivator
- (2008) Xin Liu et al. NATURE
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started